Scarica l'app Stockscreener
36.17
2.64%
0.93
Dopo l'orario di chiusura:
36.88
0.71
+1.96%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Axogen Inc Borsa (AXGN) Ultime notizie
GMED or AXGN: Which Is the Better Value Stock Right Now? - Zacks Investment Research
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now - Zacks Investment Research
Down 22.6% in 4 Weeks, Here's Why You Should You Buy the Dip in AxoGen (AXGN) - Zacks Investment Research
A passive stake above 5% in Axogen (AXGN) is held through advisory clients. - Stock Titan
AXGN | Axogen, Inc. Common Stock FinancialsRevenue Breakdown - Quiver Quantitative
Axogen, Inc.Common Stock (Nasdaq:AXGN) Stock Quote - The Chronicle-Journal
Axogen deepens nerve repair portfolio through $200m BioCircuit takeover - Yahoo Finance
Axogen announces pricing of public offering - medicalbuyer.co.in
Axogen prices $208.7 million stock offering at $42.50 per share By Investing.com - Investing.com Australia
Axogen Inc (AXGN) Shares Fall 11.5% -- What GF Score of 64 Tells Investors - GuruFocus
AXGN 424B FilingsAxogen Inc SEC 424B - Stock Titan
Axogen To Acquire BioCircuit Technologies For $200 Million To Add Sutureless Nerve Repair Platform - Pulse 2.0
Why Is Axogen Stock Tumbling Today?Axogen (NASDAQ:AXGN) - Benzinga
Axogen to buy BioCircuit Technologies for $200M - medtechdive.com
Axogen Announces $200 Million Acquisition of BioCircuit Technologies Alongside $42.50 Per Share Stock Offering - Kalkine Media
Axogen to acquire Biocircuit for $200M - BioWorld News
2 Medical-Device Stocks Lighting Up the Options Pits - schaeffersresearch.com
Form 8K Axogen Inc For: 10 September By Investing.com - Investing.com South Africa
Axogen stock falls as $208.7M offering dilutes shareholders By Investing.com - Investing.com Australia
Axogen stock falls as $208.7M offering dilutes shareholders - investing.com
Why is Axogen stock sliding today? By Investing.com - Investing.com South Africa
Axogen stock falls as $208.7M offering dilutes shareholders - Investing.com
Axogen Prices $208.7 Million Stock Offering to Fund BioCircuit Acquisition - citybiz
Axogen to Acquire BioCircuit Technologies in $200 Million Nerve Repair Deal - citybiz
Why is Axogen stock sliding today? By Investing.com - Investing.com Canada
Why is Axogen stock sliding today? - investing.com
Axogen acquires BioCircuit Technologies for $200 million - grafa.com
Axogen Announces Pricing Of $208.7 Million Public Offering Of Common Stock - TradingView
AxoGen to Acquire BioCircuit, Expanding Nerve Repair Portfolio - TipRanks
Axogen prices $208.7 million stock offering at $42.50 per share - investing.com
AXGN Looks 171.8% Overvalued on GF Value™ - GuruFocus
Axogen prices $208.7 million stock offering at $42.50 per share By Investing.com - Investing.com India
Form 8K Axogen Inc For: 10 September By Investing.com - Investing.com Canada
Form 8K Axogen Inc For: 10 September By Investing.com - Investing.com India
Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock - manilatimes.net
Axogen prices $208.7 million stock offering at $42.50 per share By Investing.com - Investing.com Canada
Axogen Prices $208.7 Million Public Offering of Common Stock to Help Fund BioCircuit Acquisition - Quiver Quantitative
AXGN: Acquisition of a pioneering sutureless nerve repair device is expected to drive growth and innovation - TradingView
Axogen to acquire BioCircuit for $200M, adds nerve repair device - Investing.com UK
Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies - GlobeNewswire
Axogen prices $208.7 million stock offering at $42.50 per share By Investing.com - Investing.com South Africa
Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock - globenewswire.com
Nerve repair without stitches is at the center of Axogen’s $200 million deal - Stock Titan
Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock - Yahoo Finance
Axogen to Acquire BioCircuit Technologies for $200 Million - Yahoo Finance
The first FDA-cleared device to repair cut nerves without stitches is now part of Axogen. - Stock Titan
Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock - The Manila Times
Axogen, Inc. agreed to acquire BioCircuit Technologies, Inc. for approximately $200 million. - marketscreener.com
Understanding the Setup: (AXGN) and Scalable Risk - Stock Traders Daily
Axogen Director Tyndall Joseph A. Disposes of 3,500 Shares at $49.70 Each - Kalkine Media
1.70%
0.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):